Planta Med 2007; 73(14): 1475-1478
DOI: 10.1055/s-2007-990261
Pharmacology
Letter
© Georg Thieme Verlag KG Stuttgart · New York

In vitro Cytotoxicity and P-Glycoprotein Modulating Effects of Geranylated Furocoumarins from Tetradium daniellii

Michael Adams1 , Anne Mahringer2 , Rudolf Bauer1 , Gert Fricker2 , Thomas Efferth3
  • 1Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Graz, Austria
  • 2Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany
  • 3German Cancer Research Centre, Heidelberg, Germany.
Further Information

Publication History

Received: April 13, 2007 Revised: September 19, 2007

Accepted: September 21, 2007

Publication Date:
08 November 2007 (online)

Abstract

Four antimycobacterial geranylated furocoumarins, from the fruits of Tetradium daniellii (Rutaceae), were tested in a bioassay using CCRF-CEM leukemia cells and their P-glycoprotein (p-gp) over-expressing subline CEM/ADR5000, to asses their cytotoxicity and effects on cellular efflux pumps. All showed considerable cell proliferation inhibition with IC50 values ranging from 1.72 to 11.02 μM against CCRF-CEM and 2.09 to 13.56 μM against CEM/ADR5000, respectively. An assay monitoring the p-gp-dependent accumulation of a calcein fluorescent dye in porcine brain capillary endothelial cells was used to study interactions of the test substances with this efflux pump. Here, they all were shown to be only weak to moderate modulators of p-gp.

Abbreviations

BBB:blood-brain barrier

CNS:central nervous system

p-gp:P-glycoprotein

PBCEC:porcine brain capillary cells

References

  • 1 Adams M, Ettl S, Kunert O, Wube A A, Haslinger E, Bucar F. et al . Antimycobacterial activity of geranylated furocoumarins from Tetradium daniellii .  Planta Med. 2006;  72 1132-5.
  • 2 Hendrikse N H, Bart J, de Vries E GE, Groen H JM, van der Graaf W T, Vaalburg W. P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography.  J Clin Pharmacol. 2001;  41 48-54.
  • 3 Demeule M, Shedid D, Beaulieu E, Del Maestro R F, Moghrabi M, Ghosn P B. et al . Expression of multidrug-resistance p-glycoprotein (MDR1) in human brain tumors.  Int J Cancer. 2001;  93 62-6.
  • 4 Ambudkar S V, Dey S, Hrycyna C A, Ramachandra M, Pastan I, Gottesman M M. Biochemical, cellular and pharmacological aspects of the multidrug transporter.  Ann Rev Pharmacol Toxicol. 1999;  39 361-98.
  • 5 Schinkel A H. P-glycoprotein, a gatekeeper in the blood-brain barrier.  Adv Drug Deliv Rev. 1999;  36 179-94.
  • 6 Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y. The antiproliferative effect of coumarins on several cancer cell lines.  Anticancer Res. 2001;  21 917-23.
  • 7 Adams M, Efferth T, Bauer R. Scopoletin and isoscopletin: the anticancer principle in Artemisia argyi, express growth inhibitory effect towards CCRF-CEM leukemia cells and multidrug resistant CEM/ADR5000 cells.  Planta Med. 2006;  72 862-4.
  • 8 Bailey D G, Malcolm J, Arnold O, Spence J D. Grapefruit juice-drug interactions.  Br J Clin Pharmacol. 1998;  46 101-10.
  • 9 Efferth T, Davey M, Olbrich A, Ruecker G, Gebhart E, Davey R. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.  Blood Cells Mol Dis. 2002;  28 160-8.
  • 10 Finney J D. Statistical methods in biological assay.  London: Charles. Griffin;  1978 58-65.
  • 11 Fellner S, Bauer B, Miller D S, Schaffrik M, Fankhanel M, Spruss T. et al . Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo .  J Clin Invest. 2002;  110 1309-18.

Prof. Dr. Thomas Efferth

German Cancer Research Centre

Im Neuenheimer Feld 280

69120 Heidelberg, Germany

Phone: +49-6221-423-426

Fax: +49-6221-423-433

Email: T.Efferth@dkfz-heidelberg.de

    >